Original Query: ALL
Previous Study | Return to List | Next Study

Autologous Bone Marrow Cell Treatment in Peripheral Atherosclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00306085
Recruitment Status : Unknown
Verified March 2006 by University of Naples.
Recruitment status was:  Recruiting
First Posted : March 22, 2006
Last Update Posted : March 22, 2006
Information provided by:
University of Naples

Brief Summary:
Implantation of bone marrow cells, including endothelial progenitor cells, into ischemic limbs has been shown to improve collateral vessel formation. In the present study the safety and feasibility of autologous blood mononuclear cells implantation will be investigated in patients with severe peripheral atherosclerosis.Twenty cases will be enrolled. Improvement in the ankle-brachial pressure index (ABI:>0.1), ischemic ulcers and angiography as well as laser doppler flow will be evaluated until six months.

Condition or disease Intervention/treatment Phase
Peripheral Vascular Diseases Genetic: Autologous bone marrow cells Phase 1

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Autologous Bone Marrow Cell Treatment in Patients With Peripheral Atherosclerosis
Study Start Date : April 2005
Estimated Study Completion Date : April 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Atherosclerosis
U.S. FDA Resources

Primary Outcome Measures :
  1. Clinical and instrumental indexes of functional impairment of peripheral atherosclerosis.

Secondary Outcome Measures :
  1. Angiographic and laser doppler measurements after six months from treatment.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   45 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Clinical diagnosis of third or fourth class of peripheral atherosclerosis

Exclusion Criteria:

  • Insuline dependent diabetes
  • Cancer

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00306085

Contact: Heidi Eisele +39 081/5665685

University of Naples Recruiting
Naples, Italy, 80134
Contact: Maria Carmela Corbisiero    +39081/5665681   
Sponsors and Collaborators
University of Naples
Study Director: Vincenzo Sica University of Naples

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00306085     History of Changes
Other Study ID Numbers: 1
First Posted: March 22, 2006    Key Record Dates
Last Update Posted: March 22, 2006
Last Verified: March 2006

Keywords provided by University of Naples:
Peripheral arterial disease,
blood marrow cells,
therapeutic angiogenesis.

Additional relevant MeSH terms:
Vascular Diseases
Peripheral Vascular Diseases
Peripheral Arterial Disease
Arterial Occlusive Diseases
Cardiovascular Diseases